-
1
-
-
0032497504
-
Parkinson's disease. First of two parts
-
Lang AE, Lozano AM(1998) Parkinson's disease. First of two parts. N Engl J Med 339: 1044-1053.
-
(1998)
N Engl J Med
, vol.339
, pp. 1044-1053
-
-
Lang, A.E.1
Lozano, A.M.2
-
2
-
-
37349004102
-
Parkinson's disease
-
Thomas B, Beal MF (2007) Parkinson's disease. Hum Mol Genet 16 Spec No. 2: R183-194.
-
(2007)
Hum Mol Genet
, vol.16
, Issue.SPEC NO. 2
-
-
Thomas, B.1
Beal, M.F.2
-
3
-
-
0030744876
-
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
-
Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
-
(1997)
Science
, vol.276
, pp. 2045-2047
-
-
Polymeropoulos, M.H.1
Lavedan, C.2
Leroy, E.3
Ide, S.E.4
Dehejia, A.5
-
4
-
-
0031990490
-
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
-
Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
-
(1998)
Nat Genet
, vol.18
, pp. 106-108
-
-
Kruger, R.1
Kuhn, W.2
Muller, T.3
Woitalla, D.4
Graeber, M.5
-
5
-
-
0242300619
-
alpha- Synuclein locus triplication causes Parkinson's disease
-
Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302: 841.
-
(2003)
Science
, vol.302
, pp. 841
-
-
Singleton, A.B.1
Farrer, M.2
Johnson, J.3
Singleton, A.4
Hague, S.5
-
6
-
-
10744230149
-
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia
-
Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164-173.
-
(2004)
Ann Neurol
, vol.55
, pp. 164-173
-
-
Zarranz, J.J.1
Alegre, J.2
Gomez-Esteban, J.C.3
Lezcano, E.4
Ros, R.5
-
7
-
-
0030882856
-
Alpha-synuclein in Lewy bodies
-
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388: 839-840.
-
(1997)
Nature
, vol.388
, pp. 839-840
-
-
Spillantini, M.G.1
Schmidt, M.L.2
Lee, V.M.3
Trojanowski, J.Q.4
Jakes, R.5
-
8
-
-
0034704752
-
A Drosophila model of Parkinson's disease
-
Feany MB, Bender WW (2000) A Drosophila model of Parkinson's disease. Nature 404: 394-398.
-
(2000)
Nature
, vol.404
, pp. 394-398
-
-
Feany, M.B.1
Bender, W.W.2
-
9
-
-
0034681471
-
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
-
Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, et al. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287: 1265-1269.
-
(2000)
Science
, vol.287
, pp. 1265-1269
-
-
Masliah, E.1
Rockenstein, E.2
Veinbergs, I.3
Mallory, M.4
Hashimoto, M.5
-
10
-
-
0037118259
-
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein
-
Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, et al. (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34: 521-533.
-
(2002)
Neuron
, vol.34
, pp. 521-533
-
-
Giasson, B.I.1
Duda, J.E.2
Quinn, S.M.3
Zhang, B.4
Trojanowski, J.Q.5
-
11
-
-
0037173006
-
Human alpha-synucleinharboring familial Parkinson's disease-linked Ala-53->Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice
-
Lee MK, Stirling W, Xu Y, Xu X, Qui D, et al. (2002) Human alpha-synucleinharboring familial Parkinson's disease-linked Ala-53 -> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A 99: 8968-8973.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 8968-8973
-
-
Lee, M.K.1
Stirling, W.2
Xu, Y.3
Xu, X.4
Qui, D.5
-
12
-
-
0036855635
-
Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies
-
Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, et al. (2002) Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 110: 1429-1439.
-
(2002)
J Clin Invest
, vol.110
, pp. 1429-1439
-
-
Neumann, M.1
Kahle, P.J.2
Giasson, B.I.3
Ozmen, L.4
Borroni, E.5
-
13
-
-
69049119262
-
Conditional transgenic mice expressing C-terminally truncated human alphasynuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons
-
Daher JP, Ying M, Banerjee R, McDonald RS, Hahn MD, et al. (2009) Conditional transgenic mice expressing C-terminally truncated human alphasynuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons. Mol Neurodegener 4: 34.
-
(2009)
Mol Neurodegener
, vol.4
, pp. 34
-
-
Daher, J.P.1
Ying, M.2
Banerjee, R.3
McDonald, R.S.4
Hahn, M.D.5
-
14
-
-
0036550101
-
Parkinson-like neurodegeneration induced by targeted overexpression of alphasynuclein in the nigrostriatal system
-
Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen TE, et al. (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alphasynuclein in the nigrostriatal system. J Neurosci 22: 2780-2791.
-
(2002)
J Neurosci
, vol.22
, pp. 2780-2791
-
-
Kirik, D.1
Rosenblad, C.2
Burger, C.3
Lundberg, C.4
Johansen, T.E.5
-
15
-
-
0345269757
-
Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: A new primate model of Parkinson's disease
-
Kirik D, Annett LE, Burger C, Muzyczka N, Mandel RJ, et al. (2003) Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease. Proc Natl Acad Sci U S A 100: 2884-2889.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 2884-2889
-
-
Kirik, D.1
Annett, L.E.2
Burger, C.3
Muzyczka, N.4
Mandel, R.J.5
-
16
-
-
5444249974
-
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: Resemblance to pathogenetic changes in Parkinson's disease
-
Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H (2004) Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. J Neurochem 91: 451-461.
-
(2004)
J Neurochem
, vol.91
, pp. 451-461
-
-
Yamada, M.1
Iwatsubo, T.2
Mizuno, Y.3
Mochizuki, H.4
-
17
-
-
33646097224
-
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): Implications for Lewy body disorders
-
Tofaris GK, Garcia Reitbock P, Humby T, Lambourne SL, O'Connell M, et al. (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J Neurosci 26: 3942-3950.
-
(2006)
J Neurosci
, vol.26
, pp. 3942-3950
-
-
Tofaris, G.K.1
Garcia Reitbock, P.2
Humby, T.3
Lambourne, S.L.4
O'Connell, M.5
-
18
-
-
33847699408
-
Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra
-
St Martin JL, Klucken J, Outeiro TF, Nguyen P, Keller-McGandy C, et al. (2007) Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J Neurochem 100: 1449-1457.
-
(2007)
J Neurochem
, vol.100
, pp. 1449-1457
-
-
St Martin, J.L.1
Klucken, J.2
Outeiro, T.F.3
Nguyen, P.4
Keller-McGandy, C.5
-
19
-
-
0035706410
-
Neurotoxicity of MPTP
-
Fukuda T (2001) Neurotoxicity of MPTP. Neuropathology 21: 323-332.
-
(2001)
Neuropathology
, vol.21
, pp. 323-332
-
-
Fukuda, T.1
-
20
-
-
0036929017
-
Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back
-
Bergman H, Deuschl G (2002) Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord 17 Suppl 3: S28-40.
-
(2002)
Mov Disord
, vol.17
, Issue.SUPPL. 3
-
-
Bergman, H.1
Deuschl, G.2
-
21
-
-
20044385568
-
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and alpha-synuclein
-
Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, et al. (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 102: 3413-3418.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 3413-3418
-
-
Fornai, F.1
Schluter, O.M.2
Lenzi, P.3
Gesi, M.4
Ruffoli, R.5
-
22
-
-
0034676997
-
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
-
Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, et al. (2000) MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport 11: 211-213.
-
(2000)
Neuroreport
, vol.11
, pp. 211-213
-
-
Kowall, N.W.1
Hantraye, P.2
Brouillet, E.3
Beal, M.F.4
McKee, A.C.5
-
23
-
-
0037159608
-
Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
-
Meredith GE, Totterdell S, Petroske E, Santa Cruz K, Callison RC, Jr., et al. (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res 956: 156-165.
-
(2002)
Brain Res
, vol.956
, pp. 156-165
-
-
Meredith, G.E.1
Totterdell, S.2
Petroske, E.3
Santa Cruz, K.4
Callison Jr., R.C.5
-
24
-
-
0035017068
-
Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice
-
Rathke-Hartlieb S, Kahle PJ, Neumann M, Ozmen L, Haid S, et al. (2001) Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice. J Neurochem 77: 1181-1184.
-
(2001)
J Neurochem
, vol.77
, pp. 1181-1184
-
-
Rathke-Hartlieb, S.1
Kahle, P.J.2
Neumann, M.3
Ozmen, L.4
Haid, S.5
-
25
-
-
0036787779
-
Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP
-
Dong Z, Ferger B, Feldon J, Bueler H (2002) Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP. J Neurobiol 53: 1-10.
-
(2002)
J Neurobiol
, vol.53
, pp. 1-10
-
-
Dong, Z.1
Ferger, B.2
Feldon, J.3
Bueler, H.4
-
26
-
-
1542617769
-
Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP
-
Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186: 158-172.
-
(2004)
Exp Neurol
, vol.186
, pp. 158-172
-
-
Song, D.D.1
Shults, C.W.2
Sisk, A.3
Rockenstein, E.4
Masliah, E.5
-
27
-
-
33747601302
-
Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice
-
Nieto M, Gil-Bea FJ, Dalfo E, Cuadrado M, Cabodevilla F, et al. (2005) Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice. Neurobiol Aging.
-
(2005)
Neurobiol Aging.
-
-
Nieto, M.1
Gil-Bea, F.J.2
Dalfo, E.3
Cuadrado, M.4
Cabodevilla, F.5
-
28
-
-
0037195109
-
Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP
-
Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, et al. (2002) Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99: 14524-14529.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 14524-14529
-
-
Dauer, W.1
Kholodilov, N.2
Vila, M.3
Trillat, A.C.4
Goodchild, R.5
-
29
-
-
0038404962
-
Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
-
Schluter OM, Fornai F, Alessandri MG, Takamori S, Geppert M, et al. (2003) Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuroscience 118: 985-1002.
-
(2003)
Neuroscience
, vol.118
, pp. 985-1002
-
-
Schluter, O.M.1
Fornai, F.2
Alessandri, M.G.3
Takamori, S.4
Geppert, M.5
-
30
-
-
3542993306
-
Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration
-
Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL (2004) Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Neurotoxicology 25: 761-769.
-
(2004)
Neurotoxicology
, vol.25
, pp. 761-769
-
-
Drolet, R.E.1
Behrouz, B.2
Lookingland, K.J.3
Goudreau, J.L.4
-
31
-
-
2642553802
-
Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice
-
Robertson DC, Schmidt O, Ninkina N, Jones PA, Sharkey J, et al. (2004) Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice. J Neurochem 89: 1126-1136.
-
(2004)
J Neurochem
, vol.89
, pp. 1126-1136
-
-
Robertson, D.C.1
Schmidt, O.2
Ninkina, N.3
Jones, P.A.4
Sharkey, J.5
-
32
-
-
0027511558
-
Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(29-aminophenyl)-1,2,3,6-tetrahydropyridine (29-NH2-MPTP): A comparative study with 29-CH3-MPTP and MPTP
-
Andrews AM, Murphy DL (1993) Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(29-aminophenyl)-1,2,3,6-tetrahydropyridine (29-NH2-MPTP): a comparative study with 29-CH3-MPTP and MPTP. J Neurochem 60: 1167-1170.
-
(1993)
J Neurochem
, vol.60
, pp. 1167-1170
-
-
Andrews, A.M.1
Murphy, D.L.2
-
33
-
-
0027786911
-
29-NH2-MPTP in Swiss Webster mice: Evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission
-
Andrews AM, Murphy DL (1993) 29-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission. J Pharmacol Exp Ther 267: 1432-1439.
-
(1993)
J Pharmacol Exp Ther
, vol.267
, pp. 1432-1439
-
-
Andrews, A.M.1
Murphy, D.L.2
-
34
-
-
0030888286
-
In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining
-
Tatton NA, Kish SJ (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77: 1037-1048.
-
(1997)
Neuroscience
, vol.77
, pp. 1037-1048
-
-
Tatton, N.A.1
Kish, S.J.2
-
35
-
-
0028784523
-
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4: 257-269.
-
(1995)
Neurodegeneration
, vol.4
, pp. 257-269
-
-
Jackson-Lewis, V.1
Jakowec, M.2
Burke, R.E.3
Przedborski, S.4
-
36
-
-
0031895005
-
Mechanisms of MPTP toxicity
-
Przedborski S, Jackson-Lewis V (1998) Mechanisms of MPTP toxicity. Mov Disord 13 Suppl 1: 35-38.
-
(1998)
Mov Disord
, Issue.13 SUPPL. 1
, pp. 35-38
-
-
Przedborski, S.1
Jackson-Lewis, V.2
-
38
-
-
33646431738
-
Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice
-
Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M (2006) Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice. Neurosci Lett 401: 183-187.
-
(2006)
Neurosci Lett
, vol.401
, pp. 183-187
-
-
Ohashi, S.1
Mori, A.2
Kurihara, N.3
Mitsumoto, Y.4
Nakai, M.5
-
39
-
-
0037469952
-
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced dopaminergic neurodegeneration in C57BL/6 mice
-
Sugama S, Yang L, Cho BP, DeGiorgio LA, Lorenzl S, et al. (2003) Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res 964: 288-294.
-
(2003)
Brain Res
, vol.964
, pp. 288-294
-
-
Sugama, S.1
Yang, L.2
Cho, B.P.3
De Giorgio, L.A.4
Lorenzl, S.5
-
40
-
-
0035789203
-
Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice
-
Specht CG, Schoepfer R (2001) Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci 2: 11.
-
(2001)
BMC Neurosci
, vol.2
, pp. 11
-
-
Specht, C.G.1
Schoepfer, R.2
-
41
-
-
0034077041
-
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
-
Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, et al. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239-252.
-
(2000)
Neuron
, vol.25
, pp. 239-252
-
-
Abeliovich, A.1
Schmitz, Y.2
Farinas, I.3
Choi-Lundberg, D.4
Ho, W.H.5
-
42
-
-
0141741347
-
Parkinson's disease: Mechanisms and models
-
Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909.
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
43
-
-
0027504812
-
Fluoxetine and desipramine selectively attenuate 29-NH2-MPTP-induced depletions in serotonin and norepinephrine
-
Andrews AM, Murphy DL (1993) Fluoxetine and desipramine selectively attenuate 29-NH2-MPTP-induced depletions in serotonin and norepinephrine. Eur J Pharmacol 250: 215-221.
-
(1993)
Eur J Pharmacol
, vol.250
, pp. 215-221
-
-
Andrews, A.M.1
Murphy, D.L.2
-
44
-
-
0030463422
-
Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 29-NH2-MPTP on serotonergic and noradrenergic nerve terminals
-
Andrews AM, Ladenheim B, Epstein CJ, Cadet JL, Murphy DL (1996) Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 29-NH2-MPTP on serotonergic and noradrenergic nerve terminals. Mol Pharmacol 50: 1511-1519.
-
(1996)
Mol Pharmacol
, vol.50
, pp. 1511-1519
-
-
Andrews, A.M.1
Ladenheim, B.2
Epstein, C.J.3
Cadet, J.L.4
Murphy, D.L.5
-
45
-
-
0141844595
-
Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine- induced caspase 3 activation: Cross-talk with alpha-synuclein and implication for Parkinson's disease
-
da Costa CA, Masliah E, Checler F (2003) Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine- induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease. J Biol Chem 278: 37330-37335.
-
(2003)
J Biol Chem
, vol.278
, pp. 37330-37335
-
-
da Costa, C.A.1
Masliah, E.2
Checler, F.3
-
46
-
-
33749246152
-
Betasynuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression
-
Fan Y, Limprasert P, Murray IV, Smith AC, Lee VM, et al. (2006) Betasynuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression. Hum Mol Genet 15: 3002-3011.
-
(2006)
Hum Mol Genet
, vol.15
, pp. 3002-3011
-
-
Fan, Y.1
Limprasert, P.2
Murray, I.V.3
Smith, A.C.4
Lee, V.M.5
-
47
-
-
0035950270
-
beta- Synuclein inhibits alpha-synuclein aggregation: A possible role as an antiparkinsonian factor
-
Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E (2001) beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an antiparkinsonian factor. Neuron 32: 213-223.
-
(2001)
Neuron
, vol.32
, pp. 213-223
-
-
Hashimoto, M.1
Rockenstein, E.2
Mante, M.3
Mallory, M.4
Masliah, E.5
-
48
-
-
9944244038
-
An antiaggregation gene therapy strategy for Lewy body disease utilizing betasynuclein lentivirus in a transgenic model
-
Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, et al. (2004) An antiaggregation gene therapy strategy for Lewy body disease utilizing betasynuclein lentivirus in a transgenic model. Gene Ther 11: 1713-1723.
-
(2004)
Gene Ther
, vol.11
, pp. 1713-1723
-
-
Hashimoto, M.1
Rockenstein, E.2
Mante, M.3
Crews, L.4
Bar-On, P.5
-
49
-
-
2542499831
-
Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease
-
Hashimoto M, Bar-On P, Ho G, Takenouchi T, Rockenstein E, et al. (2004) Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease. J Biol Chem 279: 23622-23629.
-
(2004)
J Biol Chem
, vol.279
, pp. 23622-23629
-
-
Hashimoto, M.1
Bar-On, P.2
Ho, G.3
Takenouchi, T.4
Rockenstein, E.5
-
51
-
-
0033966487
-
Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP
-
Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, et al. (2000) Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem 74: 721-729.
-
(2000)
J Neurochem
, vol.74
, pp. 721-729
-
-
Vila, M.1
Vukosavic, S.2
Jackson-Lewis, V.3
Neystat, M.4
Jakowec, M.5
-
52
-
-
0035144650
-
Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
-
Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, et al. (2001) Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J Neurochem 76: 637-640.
-
(2001)
J Neurochem
, vol.76
, pp. 637-640
-
-
Przedborski, S.1
Chen, Q.2
Vila, M.3
Giasson, B.I.4
Djaldatti, R.5
-
53
-
-
2442494278
-
Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: Intermediacy of transferrin receptor iron and hydrogen peroxide
-
Kalivendi SV, Cunningham S, Kotamraju S, Joseph J, Hillard CJ, et al. (2004) Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide. J Biol Chem 279: 15240-15247.
-
(2004)
J Biol Chem
, vol.279
, pp. 15240-15247
-
-
Kalivendi, S.V.1
Cunningham, S.2
Kotamraju, S.3
Joseph, J.4
Hillard, C.J.5
-
54
-
-
0034008852
-
Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation
-
Kanda S, Bishop JF, Eglitis MA, Yang Y, Mouradian MM (2000) Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. Neuroscience 97: 279-284.
-
(2000)
Neuroscience
, vol.97
, pp. 279-284
-
-
Kanda, S.1
Bishop, J.F.2
Eglitis, M.A.3
Yang, Y.4
Mouradian, M.M.5
-
55
-
-
0037135193
-
Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro
-
Lehmensiek V, Tan EM, Schwarz J, Storch A (2002) Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro. Neuroreport 13: 1279-1283.
-
(2002)
Neuroreport
, vol.13
, pp. 1279-1283
-
-
Lehmensiek, V.1
Tan, E.M.2
Schwarz, J.3
Storch, A.4
-
56
-
-
33244460534
-
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
-
Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, et al. (2005) Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis.
-
(2005)
Neurobiol Dis.
-
-
Klivenyi, P.1
Siwek, D.2
Gardian, G.3
Yang, L.4
Starkov, A.5
-
57
-
-
33845507061
-
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
-
Ries V, Henchcliffe C, Kareva T, Rzhetskaya M, Bland R, et al. (2006) Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc Natl Acad Sci U S A 103: 18757-18762.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 18757-18762
-
-
Ries, V.1
Henchcliffe, C.2
Kareva, T.3
Rzhetskaya, M.4
Bland, R.5
-
58
-
-
0842310838
-
Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia
-
Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA (2004) Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36: 131-137.
-
(2004)
Nat Genet
, vol.36
, pp. 131-137
-
-
Emamian, E.S.1
Hall, D.2
Birnbaum, M.J.3
Karayiorgou, M.4
Gogos, J.A.5
-
59
-
-
22744449073
-
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
-
Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, et al. (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122: 261-273.
-
(2005)
Cell
, vol.122
, pp. 261-273
-
-
Beaulieu, J.M.1
Sotnikova, T.D.2
Marion, S.3
Lefkowitz, R.J.4
Gainetdinov, R.R.5
-
60
-
-
0035964758
-
Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease
-
Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, et al. (2001) Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res 914: 48-56.
-
(2001)
Brain Res
, vol.914
, pp. 48-56
-
-
Rockenstein, E.1
Hansen, L.A.2
Mallory, M.3
Trojanowski, J.Q.4
Galasko, D.5
-
61
-
-
33746594215
-
A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling
-
Fallon L, Belanger CM, Corera AT, Kontogiannea M, Regan-Klapisz E, et al. (2006) A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol 8: 834-842.
-
(2006)
Nat Cell Biol
, vol.8
, pp. 834-842
-
-
Fallon, L.1
Belanger, C.M.2
Corera, A.T.3
Kontogiannea, M.4
Regan-Klapisz, E.5
-
62
-
-
26444489693
-
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling
-
Yang Y, Gehrke S, Haque ME, Imai Y, Kosek J, et al. (2005) Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci U S A 102: 13670-13675.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 13670-13675
-
-
Yang, Y.1
Gehrke, S.2
Haque, M.E.3
Imai, Y.4
Kosek, J.5
-
63
-
-
77649266193
-
DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway
-
Aleyasin H, Rousseaux MW, Marcogliese PC, Hewitt SJ, Irrcher I, et al. (2010) DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad Sci U S A 107: 3186-3191.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 3186-3191
-
-
Aleyasin, H.1
Rousseaux, M.W.2
Marcogliese, P.C.3
Hewitt, S.J.4
Irrcher, I.5
-
64
-
-
2442668926
-
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
-
Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160.
-
(2004)
Science
, vol.304
, pp. 1158-1160
-
-
Valente, E.M.1
Abou-Sleiman, P.M.2
Caputo, V.3
Muqit, M.M.4
Harvey, K.5
-
65
-
-
77956174949
-
Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells
-
Maj MC, Tkachyova I, Patel P, Addis JB, Mackay N, et al. (2010) Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells. Biochem Biophys Res Commun 399: 331-335.
-
(2010)
Biochem Biophys Res Commun
, vol.399
, pp. 331-335
-
-
Maj, M.C.1
Tkachyova, I.2
Patel, P.3
Addis, J.B.4
McKay, N.5
-
66
-
-
0035091767
-
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): A technical review of its utility and safety
-
Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, et al. (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76: 1265-1274.
-
(2001)
J Neurochem
, vol.76
, pp. 1265-1274
-
-
Przedborski, S.1
Jackson-Lewis, V.2
Naini, A.B.3
Jakowec, M.4
Petzinger, G.5
-
67
-
-
34147171101
-
MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity
-
Thomas B, von Coelln R, Mandir AS, Trinkaus DB, Farah MH, et al. (2007) MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Neurobiol Dis 26: 312-322.
-
(2007)
Neurobiol Dis
, vol.26
, pp. 312-322
-
-
Thomas, B.1
von Coelln, R.2
Mandir, A.S.3
Trinkaus, D.B.4
Farah, M.H.5
-
68
-
-
0034651078
-
BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain
-
Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, et al. (2000) BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20: 771-782.
-
(2000)
J Neurosci
, vol.20
, pp. 771-782
-
-
Mamounas, L.A.1
Altar, C.A.2
Blue, M.E.3
Kaplan, D.R.4
Tessarollo, L.5
-
69
-
-
66049136339
-
A comparison of modelbased (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse
-
Baquet ZC, Williams D, Brody J, Smeyne RJ (2009) A comparison of modelbased (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse. Neuroscience 161: 1082-1090.
-
(2009)
Neuroscience
, vol.161
, pp. 1082-1090
-
-
Baquet, Z.C.1
Williams, D.2
Brody, J.3
Smeyne, R.J.4
-
70
-
-
0027194462
-
New stereological methods for counting neurons
-
West MJ (1993) New stereological methods for counting neurons. Neurobiol Aging 14: 275-285.
-
(1993)
Neurobiol Aging
, vol.14
, pp. 275-285
-
-
West, M.J.1
-
72
-
-
0026339976
-
Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator
-
West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231: 482-497.
-
(1991)
Anat Rec
, vol.231
, pp. 482-497
-
-
West, M.J.1
Slomianka, L.2
Gundersen, H.J.3
-
73
-
-
7244243876
-
Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation
-
Li W, Lesuisse C, Xu Y, Troncoso JC, Price DL, et al. (2004) Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation. J Neurosci 24: 7400-7409.
-
(2004)
J Neurosci
, vol.24
, pp. 7400-7409
-
-
Li, W.1
Lesuisse, C.2
Xu, Y.3
Troncoso, J.C.4
Price, D.L.5
|